Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballard

Showing results (151-160 of 197) with videos related to

Pageof 20
Sort By:
British Journal of Pharmacology|November 3, 2010
Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptorsP Malherbe, F Knoflach, M C Hernandez, et al.
Neuropharmacology|April 15, 2004
Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodentGuy A Higgins, Theresa M Ballard, James N C Kew, et al.
Psychopharmacology|June 14, 2015
The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophreniaSanna K Janhunen, Heta Svärd, John Talpos, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Child exposure to animal feces and zoonotic pathogens in northwest Ecuador: A mixed-methods studyViviana Albán, April M Ballard, Kelsey J Jesser, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 2, 2002
Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivityTheresa M Ballard, Meike Pauly-Evers, Guy A Higgins, et al.
Obesity (Silver Spring, Md.)|March 26, 2018
Accumulating Data to Optimally Predict Obesity Treatment (ADOPT) Core Measures: Environmental DomainBrian E Saelens, S Sonia Arteaga, David Berrigan, et al.
Scientific Reports|May 22, 2021
Self-reported symptoms of arm lymphedema and health-related quality of life among female breast cancer survivorsKayo Togawa, Huiyan Ma, Ashley Wilder Smith, et al.
Neuropharmacology|July 11, 2001
Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological functionG A Higgins, A J Grottick, T M Ballard, et al.
Plos Neglected Tropical Diseases|February 23, 2026
Child exposure to animal feces and zoonotic pathogens in northwest Ecuador: A mixed-methods studyViviana Albán, April M Ballard, Kelsey J Jesser, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 15, 2004
Identification and quantitation of extractables from cellulose acetate butyrate (CAB) and estimation of their in vivo exposure levelsDecheng Ma, Walter R Wasylaschuk, Christopher Beasley, et al.
Pageof 20

Showing results (151-160 of 197) with videos related to

Sort By:
Pageof 20
British Journal of Pharmacology|November 3, 2010
Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptorsP Malherbe, F Knoflach, M C Hernandez, et al.
Neuropharmacology|April 15, 2004
Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodentGuy A Higgins, Theresa M Ballard, James N C Kew, et al.
Psychopharmacology|June 14, 2015
The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophreniaSanna K Janhunen, Heta Svärd, John Talpos, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Child exposure to animal feces and zoonotic pathogens in northwest Ecuador: A mixed-methods studyViviana Albán, April M Ballard, Kelsey J Jesser, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 2, 2002
Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivityTheresa M Ballard, Meike Pauly-Evers, Guy A Higgins, et al.
Obesity (Silver Spring, Md.)|March 26, 2018
Accumulating Data to Optimally Predict Obesity Treatment (ADOPT) Core Measures: Environmental DomainBrian E Saelens, S Sonia Arteaga, David Berrigan, et al.
Scientific Reports|May 22, 2021
Self-reported symptoms of arm lymphedema and health-related quality of life among female breast cancer survivorsKayo Togawa, Huiyan Ma, Ashley Wilder Smith, et al.
Neuropharmacology|July 11, 2001
Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological functionG A Higgins, A J Grottick, T M Ballard, et al.
Plos Neglected Tropical Diseases|February 23, 2026
Child exposure to animal feces and zoonotic pathogens in northwest Ecuador: A mixed-methods studyViviana Albán, April M Ballard, Kelsey J Jesser, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 15, 2004
Identification and quantitation of extractables from cellulose acetate butyrate (CAB) and estimation of their in vivo exposure levelsDecheng Ma, Walter R Wasylaschuk, Christopher Beasley, et al.
Pageof 20